Skip to content

Gynaelork

Active
Private limited companyfounded 2025active for 1 yearLorkenlaan(Kessel) 15, 2560 Nijlen, BelgiumKBO/BCE: BE 1029.301.840

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

Gynaelork has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15,296 and a net result of €14,629. Its solvency ranks better than 41% of 20,659 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 17-10-2025 Normal situation
Legal form
Private limited company
Registered office
Lorkenlaan(Kessel) 15, 2560 Nijlen
Activity
Specialist medical practice NACE 86220
Establishment unit
2.380.608.048 2560 Nijlen, since 17-10-2025
Financial year end
31 December
Peppol
Reachable since 11-03-2026

Who decides

Board

How it is doing

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€18,360
Turnover
≈ €120,000
estimated
Profit
€14,629
Equity
€15,296
Total assets
€28,934
2025 accounts 4 days early
Filed on 27-07-2026at the National Bank
Why 91raises riskLiquidity: current ratio 2.07, cash €374Founded in 2025lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 27-07-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 42% of its sector peers (NACE 86, micro)
Financial strength
Strong
Solvency 78
equity 52.9% of total assets
Liquidity 28
short-term debt 47.1% · cash 1.3%
Profitability 100
return on assets 50.6%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity ample (current ratio 2.07, above the usual 1.5; short-term debt: 47.1% and cash: 1.3% of total assets), and 47.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 42% on solvency, 5% on liquidity and 80% on profitability.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Liquidity: current ratio 2.07, cash €374
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 27-07-2026)
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
4 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage

Key points

  • Caution: Among the weakest 15% on equitysector median €124,506 · 20,661 companies €15,296 View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Gynaelork

What is the company number of Gynaelork?
1029.301.840. In Belgium the VAT number is the company number with BE in front: BE 1029.301.840.
Where is Gynaelork based?
The registered office is at Lorkenlaan(Kessel) 15, 2560 Nijlen.Company details
What does Gynaelork do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Gynaelork?
Private limited company (BV).
When was Gynaelork founded?
On 17-10-2025.
Is Gynaelork still active?
Yes, Gynaelork is an active enterprise in the KBO register.
What is the turnover of Gynaelork?
≈ €120,000 in financial year 2025. Estimated from the gross margin of €18,360: probably between €83,000 and €200,000, based on 48 comparable companies, NACE 86. A rough estimate.Financials
Is Gynaelork profitable?
In financial year 2025, Gynaelork made a profit of €14,629.
Where can I find the annual accounts of Gynaelork?
Gynaelork filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts at the National Bank

Companies related to Gynaelork

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.